Gallbladder Cancer
📧 Sign up to get email alerts when something new happens for Gallbladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma [EARLY_Phase 1]
This update covers an early-phase Phase 1 trial to assess the safety and feasibility of heated intraperitoneal chemotherapy (HIPEC) for high…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer [Phase 2]
A Phase II clinical trial is evaluating iparomlimab and tuvonralimab (QL1706) in combination with albumin-bound paclitaxel and lenvatinib as…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies [Phase 1, Phase 2]
This Clinical Trial Update describes a Phase 1/2 study of the ATR inhibitor peposertib in combination with the PD-L1 inhibitor avelumab and …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) [Phase 2]
Phase 2 clinical trial evaluating chemotherapy with or without binimetinib for advanced biliary tract cancers. The study is currently active…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors
A completed study comparing TDTP-RECIST with RECIST 1.1 and other volumetric methods to evaluate therapeutic response in irregular malignant…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating MP0317 in combination with chemoimmunotherapy as first-line treatment for advanced biliary tract carcino…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer [Phase 2, Phase 3]
This document provides a status update on a phase 2/3 clinical trial comparing chemotherapy before and after surgery versus after surgery al…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases [Phase 1]
Phase 1 trial evaluating pressurized intraperitoneal aerosolized nab-paclitaxel in combination with gemcitabine and cisplatin for biliary tr…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort
The TRACE-BTC study is a real-world cohort investigation examining how biomarkers and patient-reported quality of life relate to outcomes in…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering [Phase 1, Phase 2]
A Phase 1/2 study evaluating autologous tumor-infiltrating lymphocytes edited by CRISPR to inhibit CISH for metastatic gastrointestinal canc…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes [NA]
Cedars-Sinai Medical Center is recruiting for a study evaluating virtual reality to manage gastrointestinal cancer pain and improve patient-…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of trifluridine/tipiracil with oxaliplatin for advanced or metastatic biliary tract cancer…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types [Phase 1, Phase 2]
This update reports a Phase 1/2 trial of atezolizumab plus tivozanib in several immunologically cold tumor types, with the study currently s…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: EULAT Eradicate GBC
A clinical trial update indicates the study NCT06192719 titled 'EULAT Eradicate GBC' is currently recruiting to evaluate treatment for gallb…
-
CLINICAL_TRIALS other · 2026-02-05Clinical Trial Update: The PLATON Network
The PLATON Network trial (NCT05489250), sponsored by IKF GmbH at Krankenhaus Nordwest, has been terminated; the study involved hepatocellula…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Evaluation of the Safety, Tolerability and Efficacy of iNeo-Vac-R01, an Individualized mRNA Therapeutic Technology Based on Tumor Neoantigens, for Adjuvant Treatment in Patients With Biliary Malignant Tumors After Radical Resection [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 evaluation of iNeo-Vac-R01, an individualized mRNA neoantigen vaccine, as adjuvant ther…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. [Phase 2]
Phase 2 trial evaluating nivolumab plus relatlimab with gemcitabine/cisplatin as first-line treatment for advanced biliary tract cancer; the…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with lenvatinib for advanced biliary tract carcinoma. The study has completed.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
A prospective evaluation study assessing 68Ga-FAPI PET imaging for biliary cancers, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
The PERSUASION registry, a prospective German platform for biliary tract cancers including gallbladder carcinoma, has completed its expanded…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer [Phase 2]
Phase 2 clinical trial update for a regimen of gemcitabine and nab-paclitaxel with iparomlimab and tuvorilimab in unresectable advanced gall…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 trial is examining pembrolizumab alone or with lenvatinib or chemotherapy as first-line treatment for advanced biliary tract cance…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer [Phase 1]
Phase 1 trial evaluating the combination of guadecitabine and durvalumab in advanced cholangiocarcinoma, gallbladder cancer, hepatocellular …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of iparomlimab and tuvonralimab with GemOX chemotherapy and lenvatinib as conversion thera…